• iconNews
  • videos
  • entertainment
  • Home
  • News
    • UK News
    • US News
    • Australia
    • Ireland
    • World News
    • Weird News
    • Viral News
    • Sport
    • Technology
    • Science
    • True Crime
    • Travel
  • Entertainment
    • Celebrity
    • TV & Film
    • Netflix
    • Music
    • Gaming
    • TikTok
  • LAD Originals
    • Say Maaate to a Mate
    • First Impressions - The Game
    • Daily Ladness
    • Lad Files
    • UOKM8?
    • FreeToBe
    • Extinct
    • Citizen Reef
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
Snapchat
TikTok
YouTube

LAD Entertainment

YouTube

LAD Stories

Submit Your Content
Scientists call for 'urgent attention' as seriously harmful potential effects of Ozempic-like drugs found in new study

Home> News> Health

Updated 16:04 23 Apr 2025 GMT+1Published 15:13 23 Apr 2025 GMT+1

Scientists call for 'urgent attention' as seriously harmful potential effects of Ozempic-like drugs found in new study

The category of drugs have harmful potential effects

Michael Slavin

Michael Slavin

Scientists are putting out warnings after discovering some incredibly serious and harmful potential effects of drugs similar to Ozempic.

This comes from a multinational study, including researchers from across the United States, Brazil, Iran, and Israel, where 24 scientists have been investigating ‘GLP1 agonists’.

What these are is essentially a class of medications used for managing blood sugar and helping with weight loss, covering medications used for Type-2 diabetes that can trigger weight loss, such as Ozempic.

Advert

Ozempic - which has become incredibly popular amongst many celebrities who have been using it specifically for weight loss rather than for Type-2 diabetes - has had outspoken critics in recent years, including some famous faces who have spoken out against it.

Amy Schumer, who admitted to using the drug, stated she stopped using it due to side effects that left her ‘bedridden’.

Amy Schumer has spoken out about using it (Dia Dipasupil via Getty Images)
Amy Schumer has spoken out about using it (Dia Dipasupil via Getty Images)

She said: “I tried Ozempic almost three years ago and I was like, bedridden. I was like, vomiting — and then you have no energy. But other people take it and they’re all good.

"God bless them… I couldn’t lift my head off the pillow, so what’s the point?”

Advert

Researchers have added to fears around the drug, however, after calling for ‘urgent attention’ following a discovery that GLP1 agonists have a potential link to increased risks of depression and suicidal ideation.

It states that, while the class of medications may benefit those with high dopamine production, for those with low dopamine production it can have harmful effects.

The peer-reviewed study, published in Current Neuropharmacology, suggested that 'chronic use of these drugs could dysregulate dopamine signalling, potentially leading to depressive symptoms, mood disturbances, and suicidal ideation'.

Dr. Kenneth Blum, a senior author on the paper and Research Professor at Western University Health Sciences and Ariel University, said: "This study should not be ignored, despite the hype surrounding the positive clinical outcomes of GLP1 receptor agonists.

Advert

"We urge the clinical prescribing community to proceed with caution to avoid another tragic wave of 'people dying to lose weight'."

Professor Albert Pinhasov, the Provost of Ariel University, added: “While there are encouraging short-term benefits of GLP1 receptor agonists, we must acknowledge the potential risks highlighted in this study.

"These findings should encourage regulatory agencies and clinicians to investigate further, given the heterogeneity of the human population."

The European Medicines Agency have already initiated a review of GLP1 agonists, which covers drugs such as Ozempic, following reports of suicidal ideations as well as other negative side effect.

Dr. Kai Uwe Lewandowski, a Professor of Surgery at the University of Arizona School of Medicine and co-author of the paper, said: "Depression was the most commonly reported adverse event associated with these drugs, followed by anxiety and suicidal ideation. Our findings strongly support a need for further investigation to safeguard public health."

Advert

The drug has dangerous potential side effects (Steve Christo - Corbis via Getty Images)
The drug has dangerous potential side effects (Steve Christo - Corbis via Getty Images)

When approached by LADbible, a Novo Nordisk spokesperson said: "Patient safety is our top priority and we will continue to monitor reports of adverse drug reactions, including suicide and suicidal ideation, through routine pharmacovigilance.

"Independent research and preliminary findings from the UK Medicines and Healthcare Products Regulatory Agency (MHRA), as well as the U.S. Food and Drug Administration (FDA), and conclusions from a European Medicines Agency (EMA) analysis did not find an association between use of GLP-1RA medicines and the occurrence of increased risk of suicidal thoughts or actions. These findings align with data collected from our comprehensive clinical trials, including large-scale outcomes trials and observational studies.

"We welcome independent research investigating the safety, efficacy, and clinical utility of our products. We will continue to collaborate closely with the MHRA and other regulatory bodies on any analysis related to the safety of all our GLP-1RA medicines. We stand behind the safety of all of our medicines when they are used as indicated and when taken under the care of a licensed healthcare professional. The known risks associated with use of these medicines are reflected in their current approved product labelling.

"We recommend that any patients experiencing side effects while taking Novo Nordisk GLP receptor agonists report them to their healthcare provider and via the MHRA Yellow Card scheme: https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Novo Nordisk via the Customer Care Centre by calling 0800 023 2573."

Featured Image Credit: Iuliia Burmistrova via Getty Images

Topics: Mental Health, Amy Schumer, Drugs

Michael Slavin
Michael Slavin

Michael Slavin is LADbible's dedicated specialist Film and TV writer. Following his completion of a Masters in International Journalism at Salford University, he began working for the Warrington Guardian as a reporter. Throughout this he did freelance work about Entertainment for publications such as DiscussingFilm, where he was the Film and TV editor. Now, he is LAD's go to voice on all things Netflix, True Crime, and UK TV, as well as interviewing huge global stars such as Jake Gyllenhaal, Daisy Ridley, and Ben Stiller.

X

@michaelslavin98

Advert

Advert

Advert

Choose your content:

2 hours ago
3 hours ago
4 hours ago
  • 2 hours ago

    Mysterious giant structures have been discovered beneath the surface of Mars

    Researchers think it could point towards a volcano

    News
  • 2 hours ago

    Sister of woman who murdered their parents and lived with mummified bodies for years speaks out on horrific crimes

    Virginia McCullough received a life sentence last October after murdering her parents

    News
  • 3 hours ago

    Mum left hours away from 'losing her life' has foot amputated after spotting an ingrown nail

    She said she got ingrown toenails about once a week

    News
  • 4 hours ago

    Donald Trump issues scathing response to Bruce Springsteen after singer slammed 'treasonous administration'

    Donald Trump hasn't taken the comments well...

    News
  • Jeremy Clarkson addresses his current health after sharing sobering effects of Ozempic use
  • Jeremy Clarkson and Amy Schumer turned to the same weight loss drug after suffering Ozempic side effects
  • Jeremy Clarkson and Amy Schumer both suffered same sobering side effect while taking Ozempic
  • Scientists find men fit into one of three categories, according to new study